Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Intellia Therapeutics granted inducement awards consisting of 53,250 restricted stock units to 13 new employees on July 1, 2026. The awards vest annually over three years and were approved by the compensation committee as a material inducement to employment under the company’s 2024 Inducement Plan.
Key figures
- Shares Offered
- 53250
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.